Roger A. Dailey

Ophthalmology

3375 SW Terwilliger Blvd
Portland, OR 97239

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Lacrimal History - Part 37: Doyens of Dacryology Series - Lester Tallmon Jones (1895-1983).

Lacrimal History - Part 37: Doyens of Dacryology Series - Lester Tallmon Jones (1895-1983).

Journal: Seminars in ophthalmology

Published: February 13, 2025

Inflammation and Fibrosis in Orbital Inflammatory Disease: A Histopathologic Analysis.

Inflammation and Fibrosis in Orbital Inflammatory Disease: A Histopathologic Analysis.

Journal: Ophthalmic plastic and reconstructive surgery

Published: June 06, 2023

Acellular cadaveric dermal matrix grafts for orbital wall reconstruction in patients with sinonasal malignancies.

Acellular cadaveric dermal matrix grafts for orbital wall reconstruction in patients with sinonasal malignancies.

Journal: Orbit (Amsterdam, Netherlands)

Published: January 25, 2023

Proptosis and Diplopia Response With Teprotumumab and Placebo vs the Recommended Treatment Regimen With Intravenous Methylprednisolone in Moderate to Severe Thyroid Eye Disease: A Meta-analysis and Matching-Adjusted Indirect Comparison.

Proptosis and Diplopia Response With Teprotumumab and Placebo vs the Recommended Treatment Regimen With Intravenous Methylprednisolone in Moderate to Severe Thyroid Eye Disease: A Meta-analysis and Matching-Adjusted Indirect Comparison.

Journal: JAMA ophthalmology

Published: February 17, 2022

Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study.

Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study.

Journal: Ophthalmology

Published: June 13, 2021

Teprotumumab in Clinical Practice: Recommendations and Considerations From the OPTIC Trial Investigators.

Teprotumumab in Clinical Practice: Recommendations and Considerations From the OPTIC Trial Investigators.

Journal: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society

Published: January 08, 2021

Enrichment of IGF-1R and PPARγ signalling pathways in orbital inflammatory diseases: steps toward understanding pathogenesis.

Enrichment of IGF-1R and PPARγ signalling pathways in orbital inflammatory diseases: steps toward understanding pathogenesis.

Journal: The British journal of ophthalmology

Published: November 02, 2020

Radiologic imaging shows variable accuracy in diagnosing orbital inflammatory disease and assessing its activity.

Radiologic imaging shows variable accuracy in diagnosing orbital inflammatory disease and assessing its activity.

Journal: Scientific reports

Published: June 20, 2020

Non-specific orbital inflammation: Current understanding and unmet needs.

Non-specific orbital inflammation: Current understanding and unmet needs.

Journal: Progress in retinal and eye research

Published: May 14, 2020

Teprotumumab for the Treatment of Active Thyroid Eye Disease.

Teprotumumab for the Treatment of Active Thyroid Eye Disease.

Journal: The New England journal of medicine

Published: January 24, 2020

Gene Expression Profiling and Heterogeneity of Nonspecific Orbital Inflammation Affecting the Lacrimal Gland.

Gene Expression Profiling and Heterogeneity of Nonspecific Orbital Inflammation Affecting the Lacrimal Gland.

Journal: JAMA ophthalmology

Published: October 05, 2017

Success Rate of Variable Collar Size Frosted Jones Tubes.

Success Rate of Variable Collar Size Frosted Jones Tubes.

Journal: Ophthalmic plastic and reconstructive surgery

Published: June 15, 2017

Showing 1-12 of 27

Last Updated: 09/26/2026